ArticleAnnals of medicine and surgery (2012)2026

Novel drug approval by the FDA: Ekterly (Sebetralstat), oral plasma kallikrein inhibitor for treating acute attacks of hereditary angioedema.

Gulalai et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.